Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-18
2010-10-19
Shiao, Rei-Tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S302700
Reexamination Certificate
active
07816388
ABSTRACT:
Formula (I) compounds are described: Formula (I) where the radicals are as defined in the description, processes for their preparation, and their uses for the preparation of conjugates with radionuclides for use in human and animal therapy and diagnostics, particularly for the diagnosis and therapy of pathological conditions such as tumors.
REFERENCES:
patent: 5283342 (1994-02-01), Gustavson
patent: 5608060 (1997-03-01), Axworthy
patent: 5955605 (1999-09-01), Axworthy
patent: 2004/0241172 (2004-12-01), Axworthy et al.
patent: 02066075 (2002-08-01), None
patent: WO-02/066075 (2002-08-01), None
Carminati Paolo
Chinol Marco
Ginanneschi Mauro
Paganelli Giovanni
Coppins Janet L
Lucas & Mercanti LLP
Shiao Rei-Tsang
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
Biotin diaminoderivatives and their conjugates with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biotin diaminoderivatives and their conjugates with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biotin diaminoderivatives and their conjugates with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4213975